Skip to content

Insider · CIK 0002126991

Theodoros Christos Karkantzos

director

Files at COSM (Cosmos Health Inc.). First filing -, latest -.

Theodoros Christos Karkantzos files SEC Form 4 as director at COSM (Cosmos Health Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Theodoros Christos Karkantzos has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 19, 2026COSM
Cosmos Health Inc.
AGrant or award
Common Stock, par value $.001
+20,000$0.28$5,66035,000Jun 11, 2026
May 19, 2026COSM
Cosmos Health Inc.
CConversion
Restricted Stock Unitderivative
-35,000$0.00$00Jun 11, 2026

Questions about Theodoros Christos Karkantzos

Answered from the filings on this page, as of the latest one.

Is Theodoros Christos Karkantzos buying or selling?

Theodoros Christos Karkantzos has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Theodoros Christos Karkantzos's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Theodoros Christos Karkantzos has 0.

Where does Theodoros Christos Karkantzos file Form 4?

Theodoros Christos Karkantzos has filed Form 4 at COSM (Cosmos Health Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.